We are live on ! Find out more
BMRA icon

Biomerica

36 hedge funds and large institutions have $6M invested in Biomerica in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

6% more funds holding

Funds holding: 3436 (+2)

0.23% less ownership

Funds ownership: 3.51%3.28% (-0.23%)

32% less capital invested

Capital invested by funds: $8.83M → $6M (-$2.82M)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
36
Holders Change
+2
Holders Change %
+5.88%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
7
Reduced
12
Closed
2
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
+$19K

BMRA Hedge Fund Activity: Q2 2023 in Review

36 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q2 2023, worth a combined $6M — down 32% from $8.83M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BMRA positions and 2 closed out — a net gain of 2 holders — while 7 added to existing stakes and 12 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $55.6K. The largest seller was Point72 Asset Management, cutting an estimated $230K.

  • 36 institutional investors held Biomerica (BMRA) as of Q2 2023, up from 34 in Q1 2023.
  • Funds reported $6M of Biomerica stock for Q2 2023, down 32% quarter-over-quarter.
  • 4 funds opened new Biomerica positions in Q2 2023 and 2 closed out, a net change of +2 holders.
  • The largest Biomerica buyer in Q2 2023 was Geode Capital Management, an estimated $55.6K added.
  • The largest Biomerica seller in Q2 2023 was Point72 Asset Management, an estimated $230K sold.

Based on aggregated 13F filings for Q2 2023.